Uneventful splenectomy and cholecystectomy in a patient treated with anti-interleukin-6 receptor antibody therapy
- PMID: 17703320
- DOI: 10.1007/s00423-007-0217-y
Uneventful splenectomy and cholecystectomy in a patient treated with anti-interleukin-6 receptor antibody therapy
Abstract
Introduction: Interleukin-6 (IL-6) is a multifunctional cytokine that regulates various aspects of the immune responses, acute phase reactions, and hematopoiesis. In rodent models, IL-6 has been suggested to be one of the essential mediators for optimal acute phase responses to infection and tissue damage. However, in humans, the roles of IL-6 in acute phase responses after surgery remain poorly understood.
Case report: We present the first case report of successful splenectomy and cholecystectomy in a severe autoimmune-associated hemolytic anemia patient during treatment with a humanized anti-IL-6 receptor antibody.
Discussion: This unique case suggests that IL-6 is not an essential cytokine to safely perform surgical intervention and to prevent postoperative complications and that surgical intervention may not be contraindicated but can be selected as a therapeutic modality in patients treated with anti-IL-6 receptor antibody therapy.
Similar articles
-
Successful treatment of autoimmune hemolytic anemia associated with multicentric Castleman disease by anti-interleukin-6 receptor antibody (tocilizumab) therapy.Acta Haematol. 2011;126(3):147-50. doi: 10.1159/000328426. Epub 2011 Jul 14. Acta Haematol. 2011. PMID: 21757886
-
Humanized anti-interleukin 6 receptor antibody induced long-term remission in a patient with life-threatening refractory autoimmune hemolytic anemia.Int J Hematol. 2004 Oct;80(3):246-9. doi: 10.1532/ijh97.04058. Int J Hematol. 2004. PMID: 15540899
-
Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).Leukemia. 2007 Mar;21(3):511-4. doi: 10.1038/sj.leu.2404512. Epub 2007 Jan 11. Leukemia. 2007. PMID: 17215854
-
Therapeutic uses of anti-interleukin-6 receptor antibody.Int Immunol. 2015 Jan;27(1):21-9. doi: 10.1093/intimm/dxu081. Epub 2014 Aug 20. Int Immunol. 2015. PMID: 25142313 Review.
-
Clinical value of blocking IL-6 receptor.Curr Opin Rheumatol. 2009 May;21(3):224-30. doi: 10.1097/BOR.0b013e3283295fec. Curr Opin Rheumatol. 2009. PMID: 19365268 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials